当前位置:首页 - 行情中心 - 东宝生物(300239) - 财务分析 - 利润表

东宝生物

(300239)

4.39

-0.08  (-1.79%)

今开:4.45最高:4.64成交:10.77万手 市盈:0.00 上证指数:2881.97   -0.99%2019-06-14
昨收:4.47 最低:4.34 换手:0.00%振幅:0.00 深证指数:8810.13  -1.58%15:31:03

集合

竞价

利润表

按照会计年度查询:
报告期2018-09-302018-06-302018-03-312017-12-31
一、营业总收入322,296,512.05230,174,896.6498,999,088.24356,244,410.51
营业收入322,296,512.05230,174,896.6498,999,088.24356,244,410.51
二、营业总成本297,832,146.93211,950,879.4891,646,816.73333,724,472.33
营业成本251,780,208.88182,059,902.8177,852,223.56280,480,588.52
营业税金及附加3,978,898.052,637,237.261,235,698.193,746,041.06
销售费用13,801,187.518,969,684.583,981,316.5717,256,182.36
管理费用19,418,164.7115,890,909.937,498,761.8129,019,917.74
财务费用1,755,562.621,080,067.79467,587.22313,385.26
资产减值损失1,578,208.721,313,077.11611,229.382,908,357.39
三、其他经营收益--------
允许价值变动净收益--------
投资净收益64.7257.6522.331,258,757.54
联营、合营企业投资收益64.7257.6522.33-970.64
汇兑净收益--------
四、营业利润26,859,298.0119,992,558.358,329,392.7526,453,608.15
营业外收入5,954.264,317.241,963.0172,292.06
营业外支出20,000----89,958
非流动资产处置净损失--------
五、利润总额26,845,252.2719,996,875.598,331,355.7626,435,942.21
所得税4,060,470.783,216,928.251,443,225.114,019,305.1
未确认的投资损失--------
六、净利润(百万元)7.6133.9822.7816.78
少数股东损益--------
归属于母公司股东的净利润22,784,781.4916,779,947.346,888,130.6522,416,637.11
七、每股收益0.050.04----
基本每股收益0.050.040.010.05
稀释每股收益0.050.040.010.05
TOP↑